Charles Rivera: Unscripted

With Luna Federici as CEO, PicnicAI isn't just changing leaders; it's accelerating its mission to industrialize AI for health research and patient care.

As private credit swells to a $1.5 trillion industry, StoneCastle Securities appoints a veteran analyst to navigate its growing complexity and opportunity.

As the AIOps market matures, one company's recent analyst recognition highlights a crucial shift: moving from statistical AI to knowledge-based systems we can trust.

Access Vascular and Medline are betting on a new hydrogel catheter to cut costly complications. Can this blend of advanced biomaterials and scale change care?

A new partnership between AGEPHA Pharma and Close-Up Intl reveals how AI is not just a buzzword, but a critical tool for getting vital medicines to patients.

Tiffany Moon’s award celebrates compassion, but it also highlights a critical strategy for solving the home care crisis: investing in people.

With a $43M funding boost, Irish innovator CroíValve is expanding trials for its unique 'Adaptive Coaptation' device, aiming to transform treatment for millions.

CATL's new sodium-ion battery system is more than a product launch; it's a strategic move to stabilize our grids, secure supply chains, and build a more equitable energy future.

In today's complex contact centers, a green light on a dashboard means little. Nectar's new platform connects the dots between tech and talk.

After 300% growth and a $24M investment, Stars + Honey hits Target shelves. But can its 'dessert-like' collagen bars win over a skeptical market?

bioAffinity Technologies' new gene-silencing therapy kills common skin cancer cells in lab studies while leaving healthy cells untouched, hinting at a future without scars.

A Chinese AI innovator and a new European biotech just sealed a massive deal. It’s a blueprint for the future of medicine, where technology and strategy unite for patients.

Traditional life milestones are vanishing. As Canadians forge new paths, a silent financial risk emerges, prompting a critical look at our protection.

BC's approval of the Red Chris mine expansion marks a new era, blending a massive copper boost for the green economy with a landmark Indigenous consent model.

Mesa Royalty Trust's suspended June distribution is more than a missed check; it's a stark symptom of deep-seated issues facing an entire investment class.

Brewer Science's acquisition of a key chemical unit is more than a deal; it's a strategic fortification of the global semiconductor supply chain.

InsuranceAUM.com's annual meeting reveals a powerful shift: prioritizing peer collaboration to navigate market turbulence and build a more resilient future.

While the AI boom creates a global memory chip shortage, one company's proactive strategy offers a powerful lesson in how foresight and control build stability.

Following its massive Synovus merger, Pinnacle is planting its corporate flag in Atlanta, signaling a bold challenge to the city's banking titans.

A new patent embeds authenticity directly into semiconductor chips, moving beyond blockchain hype to offer a hardware guarantee against forgery for art and beyond.